Literature DB >> 27428776

Impact, determination and prediction of drug-receptor residence times for GPCRs.

Christofer S Tautermann1.   

Abstract

The residence time of a ligand on a GPCR of interest has become an optimization parameter in many examples in drug design. Long residence times can counterbalance unfavorable pharmacokinetic parameters, contributing to compound safety, and short residence times can be a tool to avoid target related side effects. Unlike the prediction and interpretation of the structure-activity relationship (SAR) of a ligand class on a receptor, the understanding and prediction of the structure-kinetics relationship (SKR) is much more demanding. Experimental and computational approaches are described, which serve to either rationalize SKR or to predict the kinetic parameters such as on-rates and off-rates.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 27428776     DOI: 10.1016/j.coph.2016.07.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  8 in total

Review 1.  Chaperome heterogeneity and its implications for cancer study and treatment.

Authors:  Tai Wang; Anna Rodina; Mark P Dunphy; Adriana Corben; Shanu Modi; Monica L Guzman; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists.

Authors:  Aniket Magarkar; Gisela Schnapp; Anna-Katharina Apel; Daniel Seeliger; Christofer S Tautermann
Journal:  ACS Med Chem Lett       Date:  2019-02-07       Impact factor: 4.345

3.  Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist.

Authors:  Robert B Laprairie; Kiran Vemuri; Edward L Stahl; Anisha Korde; Jo-Hao Ho; Travis W Grim; Tian Hua; Yiran Wu; Raymond C Stevens; Zhi-Jie Liu; Alexandros Makriyannis; Laura M Bohn
Journal:  Mol Pharmacol       Date:  2019-09-12       Impact factor: 4.436

4.  Potent Prearranged Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor.

Authors:  Ben J Jones; Rosario Scopelliti; Alejandra Tomas; Stephen R Bloom; David J Hodson; Johannes Broichhagen
Journal:  ChemistryOpen       Date:  2017-06-05       Impact factor: 2.911

5.  How and when does an anticancer drug leave its binding site?

Authors:  Pratyush Tiwary; Jagannath Mondal; B J Berne
Journal:  Sci Adv       Date:  2017-05-31       Impact factor: 14.136

Review 6.  Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.

Authors:  Shaherin Basith; Minghua Cui; Stephani J Y Macalino; Jongmi Park; Nina A B Clavio; Soosung Kang; Sun Choi
Journal:  Front Pharmacol       Date:  2018-03-09       Impact factor: 5.810

Review 7.  Binding kinetics of ligands acting at GPCRs.

Authors:  David A Sykes; Leigh A Stoddart; Laura E Kilpatrick; Stephen J Hill
Journal:  Mol Cell Endocrinol       Date:  2019-02-08       Impact factor: 4.102

8.  Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase.

Authors:  Olivier Sheik Amamuddy; Thommas Mutemi Musyoka; Rita Afriyie Boateng; Sophakama Zabo; Özlem Tastan Bishop
Journal:  Comput Struct Biotechnol J       Date:  2020-05-18       Impact factor: 7.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.